British Business Bank β 2025 Investments
5 investments dated 2025 Β· listed companies and verified rows first Β· show all
NRG Therapeutics is a biotech company developing small-molecule drugs targeting the mitochondrial permeability transition pore (mPTP) for neurodegenerative diseases such as ALS and Parkinson's.
BiotechHealthtechLongevity
Neil Miller(CEO)inRichard Rutter(CSO)inGrant Hawthorne(COO)inClaus Sundgreen(Chief Medical Officer)inPaul Thompson(CDO)in
BoardJonathan Savidge(Independent Non Executive Chair)
Co-investorsCriteria Bio VenturesNovartis Venture FundSV Health InvestorsM VenturesDementia Discovery Fund
Dxcover provides a platform for rapid development of liquid biopsies to detect cancer and other diseases.
AI & Machine LearningBiotechHealthtechMedical Devices
Co-investorsEos AdvisoryScottish EnterpriseAlba EquityMaven Capital Partners
Freedom One Life builds the Series 5, a premium electric powered wheelchair designed by a powerchair user for both everyday use and outdoor adventures, offering up to 60km range and hybrid indoor/outdoor capability.
HardwareHealthtechMedical DevicesGlasgow, GB
Alex(Founder)
Co-investorsMurray CapitalThe FSE Group
Inntelo AI is an AI-native platform for the hospitality and real estate sectors that combines agentic and conversational AI to handle guest communications, operations and planning, personalisation and upselling, and a customer data platform.
AI & Machine LearningPropTechSaaS
Asif Alidina(Founder)in
Co-investorsHaatchAntlerLook AI Ventures
Osney Capital is a venture capital firm specializing in early-stage cybersecurity companies in the UK, typically investing in rounds under Β£5m.
CybersecurityUK, GB
Co-investorsEnterprise Capital FundsIronGate Capital Advisors
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.